Mt. Jackson, VA – February 24, 2025: StageBio is honored to announce they received Scientist.com’s Supplier Performance Recognition Award for 2024.

This Supplier Recognition Award acknowledges StageBio’s outstanding performance in offering drug discovery research services for their Research & Development sourcing platform in 2024.

This recognition to StageBio highlights their proven high responsiveness rate and commitment to delivering top-tier Histopathology, Pathology Services, H&E Staining, and Immunohistochemistry to our clients.

“Our team is committed to delivering superior service to our clients, and we appreciate the opportunity to be recognized. As a leading histology and histopathology provider for clinical and nonclinical research industries, we look forward to continuing to bring our clients to new heights for 2025.” - Wendy Sauer, Head of Commercial.

To learn more about StageBio and their offerings, please visit www.stagebio.com.

About StageBio

StageBio is a leading provider of GLP-compliant necropsy, histology, pathology and specimen archiving services for the biopharmaceutical, medical device, academic, government and contract research industries. The company operates four GLP laboratories as well as two GLP specimen archiving facilities in the U.S. and Europe, with substantial continued investment in facility and technology infrastructure to meet the growing demand for high-quality histopathology services globally. StageBio has a team of 25 board-certified veterinary pathologists and more than 100 laboratory personnel on staff supporting our unified commitment to quality, scientific integrity and client satisfaction. Learn more at www.stagebio.com.